04Evidence A

Don’t buy weight‑loss pills, coffee, candies, or “enzymatic plums” (plums claimed to be soaked in enzymes) that promise rapid results

These products are often found with a diet drug (sibutramine) added in secret. It used to be a weight-loss drug, and China stopped it in 2010. Overweight people aged 55 or older, who had heart disease or diabetes, took it for more than 3 years. Non-fatal heart attack risk was about 30% higher, and stroke risk was about 36% higher. The weight lost was only 1.7 kg more. By the time a spot check finds it, you have already swallowed it.

Cost

Zero. In fact, you’ll save the money you’d otherwise spend…

Benefit

The SCOUT trial involved 9,804 participants aged 55 or older who were overweight or obese and had cardiovascul…

Cost

Zero. In fact, you’ll save the money you’d otherwise spend on these products. The hard part is accepting that there’s no such thing as “losing several pounds in a week.”

Benefit

The SCOUT trial involved 9,804 participants aged 55 or older who were overweight or obese and had cardiovascular disease or type 2 diabetes. They were randomly assigned to receive sibutramine or placebo for an average of 3.4 years. The primary endpoints were several predefined adverse events: non‑fatal myocardial infarction, non‑fatal stroke, cardiac arrest with successful resuscitation, and cardiovascular death. The incidence rates were 11.4% in the drug group versus 10.0% in placebo, giving a hazard ratio of 1.16 (95% CI 1.03–1.31, P = 0.02). In other words, treatment raised the risk of any such event by roughly 16%, with the true increase likely ranging from 3% to 31%. Non‑fatal heart attacks occurred in 4.1% vs 3.2% of participants (hazard ratio HR 1.28, 1.04–1.57), a 28% relative increase in risk; non‑fatal strokes appeared in 2.6% vs 1.9% (hazard ratio HR 1.36, 1.04–1.77), a 36% increase. No statistically significant rise in cardiovascular or overall mortality was detected. On average, the sibutramine group lost only 1.7 kg more than placebo. Based on safety concerns, China’s former State Food and Drug Administration ruled in October 2010 that the benefits of sibutramine did not outweigh its risks, ordering cessation of its production, sale, and use; both sibutramine and phenolphthalein are prohibited in foods and dietary supplements.

Original sources

James WPT et al. (2010). Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. NEJM. https://doi.org/10.1056/NEJMoa1003114;天津市市场监督管理委员会. 警惕部分食品中违法添加「盐酸西布曲明」和「酚酞」. https://scjg.tj.gov.cn/tjsscjdglwyh_52651/hdpt/cjwtyxfts/202007/t20200720_2972549.html

Open source link
Book note

SCOUT enrolled a high-risk group who already had heart disease or diabetes. This trial did not prove that healthy young people would have the same events. But because you cannot tell who is high-risk, the regulator simply took it off the market. Another ingredient often added in secret is phenolphthalein. It was originally a laxative. Taking too much of it for a long time can throw off the body's electrolytes and trigger an irregular heartbeat. How to tell: a real weight-loss drug is a prescription drug, and the approval number can be looked up at a pharmacy or a hospital. Something sold under the name of "coffee," "candy," "plums," or a "meal replacement," that also promises you will drop several jin in 1 week, should by definition have no drug effect. If it has a drug effect, something was added. The original text that stopped sibutramine is notice «国食药监办» [2010] No. 432, posted on the National Medical Products Administration website. What is cited here is a page on which the Tianjin market supervision administration retells it. The 2 sentences "risks outweigh the benefits" and "production, sale, and use stopped in October (10) 2010" can be checked word for word there.

My note